Watch, but don't buy yet as the party may be over.
Price and time parameters have come together on the daily chart.
Rising on positive news for a cancer treatment.
Obesity costs are a  pain point, which  often create good investments.
Intuitive Surgical looks way overpriced.
A Vical drug stirs high expectations, but the bull case deserves scrutiny.

Healthcare Names to Chew On Real Money Pro($)

I've come up with a trio of plays, as it's just too tough to go with a single name in this group.
I am looking for a pullback to the recent low for a buy entry.
What impresses me is that AMN did not sell off with the major indexes.
If shares fall to under $40, I would take another look.

Columnist Conversations

The iShares TIPS Bond Fund (TIP) has retraced 38% of its 2013 decline. The technicals indicators are trending ...
A survey by Janney Capital Market of McDonald's (MCD) franchisees indicated positive expectations for same-sto...
In addition to the Oscillator chart shown in my column each day, note how oversold Nasdaq is when we use the 3...
After yesterday's huge reversal, futures are pointing to another higher day in the market. Maybe equities can...


Columnist Tweets


Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.